REGEN BIOPHARMA, INC. Net Income (Loss) Attributable to Noncontrolling Interest
REGEN BIOPHARMA, INC. (RGBP) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2021-08-04.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2021-08-05
- REGEN BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2020-09-30 was $0.00.
- REGEN BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- REGEN BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$7.29K.
- REGEN BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2019-06-30 was $4.79K.
- REGEN BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for fiscal 2020 was $0.00.
- REGEN BIOPHARMA, INC. net income (loss) attributable to noncontrolling interest for fiscal 2019 was $0.00.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-04 | $0.00 derived: sum of 2 quarters · filed 2021-08-05 | $0.00 10-K · filed 2021-08-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2019-09-30 | -$7.29K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-04 | -$2.50K derived: sum of 2 quarters · filed 2021-08-05 | $0.00 10-K · filed 2021-08-04 | |
| 2019-06-30 | $4.79K 10-Q · filed 2021-08-05 | $7.29K 10-Q · filed 2021-08-05 |